Recent rapid technological advances are producing exposure data sets for which there are no available data quality assessment tools. At the same time, regulatory agencies are moving in the direction of data quality assessment for environmental risk assessment and decision-making. A transparent and systematic approach to evaluating exposure data will aid in those efforts. Any approach to assessing data quality must consider the level of quality needed for the ultimate use of the data. While various fields have developed approaches to assess data quality, there is as yet no general, user-friendly approach to assess both measured and modeled data in the context of a fit-for-purpose risk assessment. Here we describe ExpoQual, an instrument developed for this purpose which applies recognized parameters and exposure data quality elements from existing approaches for assessing exposure data quality. Broad data streams such as quantitative measured and modeled human exposure data as well as newer and developing approaches can be evaluated. The key strength of ExpoQual is that it facilitates a structured, reproducible and transparent approach to exposure data quality evaluation and provides for an explicit fit-for-purpose determination. ExpoQual was designed to minimize subjectivity and to include transparency in aspects based on professional judgment. ExpoQual is freely available on-line for testing and user feedback (exposurequality.com).
Introduction
The National Academies of Sciences (NAS National Academy of Sciences, 2012) has defined exposure science as "the collection and analysis of quantitative and qualitative information needed to understand the nature of contact between receptors (such as people or ecosystems) and physical, chemical, or biologic stressors. Exposure science strives to create a narrative that captures the spatial and temporal dimensions of exposure events with respect to acute and long-term effects on human populations and ecosystems." While early human exposure assessments relied predominantly on measurements of chemicals in environmental media such as air, soil, water and foods, over time there has been increased use of other approaches including biomonitoring (measurements in matrices such as blood, urine, hair), modeling, low cost sensors (including technologies operated by members of the general public; e.g., https://www.epa.gov/air-research/citizen-scienceopportunities-monitoring-air-quality-fact-sheet), computational approaches, market survey data, and social media-derived data. Similarly, novel data streams such as those generated as a result of the capture of digital data (often referred to as Big Data) are increasingly used for various scientific purposes, including human health assessments (Lazer et al., 2014) . This collection of varied sources of exposure data offers opportunities for expanding our understanding of the extent, types, sources and variability of exposures to a wide array of chemical stressors. For example, the ability to estimate human exposures to fragrance chemicals using market survey data and predicting the influenza rate is now possible -with varying degrees of success -using internet searches (Comiskey et al., 2015; Lazer et al., 2014) .
Legislation and regulatory guidance documents now specifically call for estimates of total or aggregate human exposure (EFSA (European Food Safety Authority), 2012; SCCS, 2016; Toxic Substances Control Act (TSCA), 2013), thus increasing the demand for more detailed and diverse datasets in order to accurately cover multiple sources and routes of exposure. In addition, partly as a consequence of the success in reducing reliance on animal testing (e.g., Frank R. Lautenberg Chemical Safety for the 21st Century Act; 15 USC Ch. 53: Toxic Substances Control), there is increased focus on the use of human data (including exposure data) for environmental regulatory decision-making.
However, not all sources and types of human exposure data are of equal quality. The need to include a data quality assessment as part of evaluation of exposure-outcome data in risk assessment and public health decision-making has been recognized (USEPA (US Environmental Protection Agency), 2018; NTP (National Toxicology Program), 2015). Approaches to assessing exposure data quality for decision-making have been developed but an additional step is needed as any approach should also consider the level of quality needed for the ultimate use of the assessment. As recognized by the USEPA (US Environmental Protection Agency) (2000): "Data quality does not exist in a vacuum; one must know in what context a data set is to be used in order to establish a relevant yardstick for judging whether or not the data set is adequate." Changes in the exposure landscape make this a propitious time for the development of a holistic human exposure data evaluation instrument that include consideration of end-uses of the data.
How can we evaluate exposure data to determine whether the quality is suitable for a given use, i.e., whether the data are "fit for purpose"? Data quality evaluation approaches have been developed for traditional approaches to exposure assessment (e.g., Money et al., 2013) . For some newer approaches to collecting exposure data, efforts have similarly been made to define aspects of data quality (e.g., citizen science, Rose et al., 2016; Wiggins et al., 2011) . Further, regulatory bodies in Europe have released guidance documents on uncertainty analysis in scientific and/or exposure assessment, with a view to increase transparency in conclusions drawn from exposure assessments and related data (BfR Federal Institute for Risk Assessment, 2015; EFSA (European Food Safety Authority), 2016); these efforts have included frameworks for evaluating mathematical model validity, accuracy and uncertainty in the exposure domain. But the question of how such approaches can be applied to analyses using new and alternative data sources is as yet unanswered. Various fields including occupational health, toxicology, and medicine have developed approaches for rigorously and transparently assessing data quality, but there is as yet no holistic approach for assessing both quality of measured and modeled exposure data and incorporating the results into a fit-for-purpose assessment.
Using key elements from existing approaches to assess exposure data quality, an instrument called ExpoQual has been developed. This tool evaluates the quality of human exposure data -both traditional sources of exposure data as well as newer and developing approacheswith a focus on quantitative data. The following four core principles provide the foundation for our approach to the development of a human exposure data evaluation instrument:
1. The focus is to assess the quality of the data. 2. Whether or not any particular data are included or excluded in decision-making is a management decision and relates to whether the data are fit for the purpose at hand. 3. The evaluation process should be transparent and -to the extent possible for any schema that necessarily involves some degree of professional judgement -reproducible. 4. The practical implementation of the instrument is as important as the scientific details, and should leverage the latest advances in web technology.
In this paper, data quality terms used in ExpoQual are first reviewed as relevant terms have been assigned different meanings in past literature. The structure of ExpoQual is then explained along with a case study example to demonstrate the instrument.
Terminology
Certain words and terms hold various meanings within data quality evaluation. ExpoQual incorporates several recognized terms. These are highlighted as follows (IPCS International Programme on Chemical Safety, 2008):
Data: any information that contributes to, or is relevant to, a particular exposure assessment. This includes not only numerical values or estimates, but also other information including default values, theory from first principles or basic science, computer programs, surveys, demographic data, census information, graphs, formula, and model parameters.
Quality: Most existing frameworks refer to the concept of quality. In some cases, quality is explicitly defined, but in others it is more ambiguous. In ExpoQual, quality is a measure set by the user based on the level of confidence in the exposure data for the user's specific purpose. This is a relative -not an absolute -term.
Tiers: Most frameworks use a tiering system of some kind, with the significance or meaning of a given tier differing depending on the particular context of the framework. For example, a tier can be associated with a level of data quality or can signify different levels of model refinement. The directionality of the numbers assigned to tiers can also vary, with smaller tier numbers associated with both higher quality and less refinement. Thus, the meaning of "tier" varies both conceptually and in terms of directionality. Within this document, tiers refer to levels of quality, with tier 1 being the highest level of quality, tier 2 being intermediate, and tier 3 being the lowest.
Uncertainty: Uncertainty is any aspect of a model, parameter, data or belief involving a lack of knowledge. A related concept is confidence: while not addressed in detail in most guidance documents or frameworks, confidence could be considered to be the converse of uncertainty. If uncertainty is sufficiently low or has a minimal impact on the decision being made, then confidence is high and vice versa.
Method
In the development of ExpoQual, the literature on data quality assessment approaches for specific data types was explored to obtain an understanding of key ideas and common themes and techniques. Exposure data evaluation techniques utilized in the fields of environmental monitoring, biomonitoring, epidemiology, toxicology, citizen science, computational exposure science, uncertainty assessment, finance, statistics, and decision theory were examined (Ågerstrand et al., 2011; Basel Committee on Banking Supervision. BASEL II, 2005; Draper, 1995; IOM Institute of Medicine, 2010; Nethery et al., 2008; Tielemans et al., 2002; Wiggins et al., 2011) . Publications that included methods for assessing quality of exposure data and/or evaluating the output of mathematical models were reviewed to identify high level concepts for instrument development. Publications that were site-or chemical-specific, or those that evaluated quality of data for a specific exposure-outcome association were considered only when approach could be generalized. Over 180 publications/documents were reviewed, including those that did not necessarily incorporate a quality framework but contained information/concepts that could be used for the building of the instrument. Supplement 1 summarizes key aspects of the existing literature that informed the development of ExpoQual.
While examining the literature the following questions were investigated: What elements of an evaluative instrument are critical for ensuring transparency and reproducibility while recognizing the need for flexibility? What are the common themes that cut across the seemingly disparate types of exposure data so that one instrument is suitable regardless of data source?
In general, many frameworks, systems and methodologies exist for evaluating different types of exposure data stemming from clinical, epidemiological, biomonitoring and toxicological studies. Broadly speaking, for these domains, the focus has been on methods for evaluating the quality of data produced, such as Klimisch scores (Klimisch et al., 1997) or the BEES-C Instrument (LaKind et al., 2014) . On the other hand, in the area of computational exposure science and risk assessment, the primary focus has been on tiering approaches (referring to level of detail/refinement, e.g., RISK21), model validation and uncertainty analysis (EFSA (European Food Safety Authority), 2016; Meek et al., 2011) . Systematic approaches to analysis of exposure data are important. Without such approaches, evaluations will lean more heavily on expert judgement, which can reduce transparency and increase the likelihood of disagreements regarding whether data are sufficient for a given purpose (Kase et al., 2016) .
Key lessons from the literature review
One challenge in developing an instrument for evaluating human exposure data quality (modeled or measured) is to ensure that the hallmarks of data quality (appropriateness, accuracy, integrity and transparency; IPCS International Programme on Chemical Safety, 2008) can be defined across both existing and emerging types of exposure data. No acceptable ready-to-use instrument capable of assessing the quality of current or emerging types of human exposure and environmental data could be identified from the literature review. However key concepts were revealed which provided the framework for ExpoQual and enabled approaches to allow both modeled and measured data to be considered either in parallel or in sequence. The key items in designing the instrument were structure, level of detail, and inclusion of a fit-for-purpose step. These are described here.
Structure: The main approaches to evaluating data are scoring systems, heat maps or decision trees. While scoring systems offer the user the ability to quantitatively rank or weight data from various sources, they can mask the effect of important and low quality elements (LaKind et al., 2014; Tielemans et al., 2002) . Decision trees offer logical approaches and chart each decision, but can be complex and difficult to use. Many of the frameworks ultimately concluded with a tiering approach of high, medium or low quality; we selected this approach, with a heat map construct for measured data and an extent (high, medium, low)/direction approach for modeled data.
Level of detail: There is always a tension between developing a framework with minimal guidance which is more user-friendly in terms of time required for data review but leaving conclusions based heavily on professional judgment resulting in reduced transparency and reproducibility versus too much/too explicit guidance which is more transparent but unwieldy in terms of time needed for completion and viewed as prescriptive and heavy handed. To help ensure reproducible transparent results on the assessment of measured data, ExpoQual provides detailed guidance. However, not every aspect of data quality (e.g., every component of QA/QC) was included as these topics have been well-described in existing literature. Inclusion would render the instrument less user-friendly. ExpoQual does include explicit definitions of quality and uncertainty in defining quality tiers so that one user's output from the instrument can be replicated by another user.
For modeled data evaluation, simple, qualitative schemes for uncertainty analysis which are easily applied and communicated are used in ExpoQual. The more sophisticated approaches to techniques like 2D Monte Carlo or bootstrapping (EFSA (European Food Safety Authority), 2016) in uncertainty analysis require considerable technical inputs with specific implementation details dependent on the structure of the model and data being assessed; these complex approaches are not readily generalizable and are not included in ExpoQual.
Inclusion of fit-for-purpose: Some existing frameworks specifically include a decision-making element (i.e., a recommendation to use or discard exposure data for decision-making) (e.g., Tielemans et al., 2002) while others stop at the end of the quality assessment (LaKind et al., 2014) . Because the instrument proposed here is meant to apply across exposure data types and uses, and because it is meant to support decision-making, ExpoQual includes points at which users can decide whether the data are of sufficient quality for their purpose but does not prescribe cut-offs (i.e., there are no a priori decisions stating whether a given dataset is sufficient for use or not). Each decision depends on the combination of quality and purpose of use.
Results

Quality of human exposure data: evaluation instrument -ExpoQual
After considering available approaches the ExpoQual instrument was designed to assess two components: 1. Measured data-i.e., the inputs/parameters/datasets; 2. Modeled data -i.e., the conceptualization or mathematical representation of the exposure scenario.
Measured data encapsulates direct measures of exposure such as concentration data from environmental media measurements, biomonitoring and information from personal monitoring devices and sensors, as well as other information such as exposure factors (consumption rates, inhalation rates, dermal transfer, etc.), and consumer habits and practices. Modeled data is the output of a calculation, generally involving concentration data of the level of a stressor in a specific medium (often measured or sometimes itself the output of another model) coupled with estimated levels of intake of the medium based on human habits and practices. Each type of data requires a unique approach to data quality evaluation. At the same time, a holistic instrument should ideally provide a linkage between the two because in many cases an exposure assessment begins with measured data and then uses the data in a model to reach an estimate of human exposure.
The ExpoQual framework has been developed as an on-line tool with fit-for-purpose components after each evaluative step. The assessment of multiple sources of data along with report preparation proceeds through the four general steps as follows.
Step 1: measured data evaluation
In ExpoQual, measured data are evaluated using elements from the BEES-C (LaKind et al., 2014) . Exposure factors were added to enable evaluation of various types of measured data beyond biomonitoring. Elements from the BEES-C pertaining to exposure data quality were included in ExpoQual (Table 1) . Elements related to epidemiological design, analysis and reporting may be considered for addition as a separate instrument module at a later date.
An aspect of measured data absent from the BEES-C approach relates to exposure factors. These are situational elements that influence exposure and include parameters that describe the extent of chemical contact, inhalation rates, exposure frequency and duration. ExpoQual uses the same high, medium and low tier categorization as is described in the US Environmental Protection Agency's (EPA) assessment criteria for each factor (see EPA's Exposure Factors Handbook; USEPA (US Environmental Protection Agency), 2011). EPA ratings for this category include judgment on soundness, applicability, utility, clarity, completeness, variability and uncertainty of the data. The same qualitative approach is recommended for exposure factor determination in ExpoQual.
The measured data segment of ExpoQual is shown in Fig. 1 . Each element relevant to the measured data is assigned a tier using specific guidance provided in Table 1 . The user conducts an evaluation of a given data set (i.e., data from a publication or other data source) categorizing each element for that data as Tier 1, 2 or 3, or not applicable (N/A). Upon completion of tiering each element, the user is able to visualize the strengths and weaknesses of the data. Step 2: measured data fit-for-purpose conclusion Different end uses of exposure data require different levels of quality and sophistication. It is the responsibility of the user to examine the relevance and tiering for measured data and to decide whether or not the whole database -or parts of the database -are suitable for their purpose. The fit-for-purpose portion of the framework allows the user to make a decision of quantitatively fit-for-purpose, qualitatively fit-forpurpose or not fit (and to include justification if warranted). For example, the user may have made an a priori decision that only studies with acceptable sampling protocols which demonstrate quality assurance methods and precautions to prevent sample contamination can be included in the decision-making process. Components outlined in Table 1 would be used to assess the study. Tier 1 and Tier 2 responses indicate that the study meets the criteria as high or acceptable. Tier 3 data sources would result in a not-fit-for-purpose decision for use of those data.
If only measured data are ultimately needed then once the first fitfor-purpose step is completed, the ExpoQual process can be finalized and a report generated as shown in Fig. 2 . If the measured data are to be used as model inputs, the user progresses to the last evaluation module of ExpoQual.
Step 3: modeled data evaluation
Exposure estimates that are the output of a particular model, whether based on a simple calculation involving an algebraic relationship with point estimates for model parameters or a sophisticated analysis involving very large data sets and high-performance computing, can conceptually be assessed using the same approach.
The modeled data evaluation part of ExpoQual includes three elements: data uncertainty, model uncertainty and scenario uncertainty. For each of these elements, the user assesses both direction and magnitude of uncertainty, which can be informed by the quality assessment in the previous steps. A simple three point scale (high, medium and low) to indicate magnitude is used, with a direction associated with each to indicate whether the uncertainty is an over-or under-estimate of the true value. In order to have a transparent process, the user is able to include justification for decisions around degree and direction of uncertainty. The following describe tiering for uncertainty (adapted from EFSA (European Food Safety Authority), 2016), which are applied to data, model, and scenario elements:
• Low uncertainty: Solid and complete data available, parameters and their relationship in model known and validated; strong evidence in multiple references with most authors coming to the same conclusions, or considerable and consistent experience from field observations.
• Medium uncertainty: Some or only incomplete data available; evidence provided in small number of references; some model assumptions not validated, authors' or experts' conclusions vary, or limited evidence from field observations, or solid and complete data available from other species which can be extrapolated to the species being considered.
• High uncertainty: Scarce or no data available; strong assumptions in model and scenario that are not validated, evidence provided in unpublished reports, or few observations and personal communications, and/or authors' or experts' conclusions vary considerably.
In each case, the direction of the uncertainty is indicated Fig. 1 . Portion of measured data evaluation in ExpoQual*(ExpoQual available at exposurequality.com). All evaluative components are shown in the case study example in Fig. 5 . *Note that all content in the screenshots in this publication are hypothetical and for demonstration purposes only and do not relate to any real study. (overestimate, underestimate, or both), and applied to the data, scenario and model elements.
• Data uncertainty: The decision regarding data uncertainty stems directly from the results of the quality evaluation of the measured data. The user assesses the results from the first step (measured data) and decides on the direction and magnitude of the uncertainty.
• Model uncertainty: This describes any uncertainty associated with the mathematical structure of the exposure model, or gaps in knowledge with regards to the relationship between physical quantities and how these are described mathematically.
• Scenario uncertainty: Scenario uncertainty arises from errors or issues with how the exposure assessment and model are described or characterized.
• Overall uncertainty: The overall uncertainty is the combined effect of the data (in turn informed by quality), model and scenario uncertainties, and is based on the expert judgement of the user.
A hypothetical example is shown in Fig. 3 . There may be situations in which uncertainty could result in either an over-or underestimate of exposure; this is indicated by the parallel arrows.
Step 4: modeled data fit-for-purpose conclusion
After completion of the model uncertainty component of ExpoQual, the user will have an assessment of the confidence and direction of uncertainty associated with modeled data for individual studies and the overall database. This is used in conjunction with the purpose of the data to determine which if any of the modeled exposure data are fit-forpurpose, either qualitatively or quantitatively. An excerpt from the hypothetical modeled data report is shown in Fig. 4 . On completion of the modeled data portion of ExpoQual, a final report is generated.
Practitioner's use of ExpoQual
At the completion of the ExpoQual process, each relevant aspect of data confidence will have been assessed and the practitioner will have a clear, transparent visual assessment of confidence in each component of the measured and modeled data; it is left to the professional judgment of the practitioner to decide whether the data are sufficient for their needs.
All exposure data remain available for use as ExpoQual is agnostic regarding decisions to include or exclude data for any given purpose. The fit-for-purpose component of the instrument is key to the justification for inclusion or exclusion of existing data.
In general, whether the exposure data are fit for purpose is inextricably tied to the tolerability of risk argument (Altar et al., 2008) . When high value is assigned to a true result, and the harm associated with a false result is low, then a lower weight of evidence is needed due to the higher tolerance for uncertainty and ambiguity. In contrast, if the harm of a false result is high, there will be a lower tolerance for error. However, that tolerance will likely vary depending on cultural, geographic and other factors that influence decision-makers and a one-sizefits-all set of criteria is not practical.
Case study
A case study is provided to demonstrate the use of ExpoQual. Several papers were identified that could be used for case study. The publication by Blando et al. (2010) describing measured air concentrations for 1-bromopropane (1-BP) among dry cleaners was selected to test the use of ExpoQual. The information provided in the paper enabled sufficient scenario information and exposure data to examine multiple inhalation and dermal models using ExpoQual. The US EPA is currently evaluating 1-BP as part of its first set of assessments under the amended Toxic Substances Control Act (Frank R. Lautenberg Chemical Safety for the 21st Century Act). 1-BP has a variety of uses and is considered a substitute for perchloroethylene in dry cleaning establishments. Blando et al. collected personal breathing zone samples over 4 days for different occupational categories and area air samples in different locations in four dry cleaning facilities. Samples were analyzed for 1-BP by capillary gas chromatography with flame ionization detection. The personal 8 h time-weighted average air sample concentrations (n = 14) ranged from ND to 54 ppm and the areas sample concentrations (n = 12) ranged from ND to 35.12 ppm.
The data and contextual information described in Blando et al. (2010) were used in combination with IH SkinPerm and a qualitative model (Qualitative Exposure Assessment Checklist; QEAC) to estimate worker exposures via the dermal and inhalation routes of exposure, respectively.
Dermal model
IH SkinPerm simulates absorption of chemical substances through the skin from an external exposure. The dermal absorbed dose can be estimated for workers handling chemical substances. Four dermal exposure scenarios relevant to occupational settings can be simulated using IH SkinPerm. IH SkinPerm accounts for absorption and evaporation simultaneously. Quantitative structure-activity relationships (QSAR) are used to estimate permeation through the transcellular and intercellular pathways in the stratum corneum. More detailed explanations of the QSARs in IH SkinPerm are published elsewhere (Tibaldi et al., 2014) . For the case study, two types of dermal exposures were modeled for 1-BP use conditions in dry cleaning facilities. 
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Environmental Research 171 (2019) 302-312 Scenario 1 models dermal absorption from airborne vapor concentrations of 1-BP vapor using reported upper end values; Scenario 2 estimates dermal absorption from repeated deposition (e.g., periodic contact with wet garments) of 1-BP onto skin over time considering conditions generally described by Blando et al. Dermal absorption behavior is predicted by IH SkinPerm from physicochemical properties of 1-BP. Therefore, values for substance properties such as molecular weight, vapor pressure (Pa), water solubility, density, log octanol/ water partition coefficient (Kow) at skin pH of 5.5, and melting point data were retrieved from publicly-available literature. Exposure modeling inputs for each scenario are shown in Table 2 . The dermal uptake of 1-BP from Scenario 1 vapor conditions was estimated by IH SkinPerm to be 1.5 mg for the eight hour vapor exposure. In Scenario 2 the dermal absorbed mass was estimated to be 87.4 mg following repeated hand exposure rate of 1.4 mg/cm 2 /h over 8 h.
Inhalation model
The data in Blando et al. (2010) were assessed with the purpose of using the data as input for a qualitative inhalation model. Blando et al. was primarily a field study to measure exposures and provides summary measured exposure data. Adapting such information as the basis for modeling inhalation exposure is not straightforward. However sufficient information was provided in the paper to develop a scenario and model air concentrations using qualitative judgment tools, such as in the AIHA tool "Qualitative Exposure Assessment Checklist" (AIHA (American Industrial Hygiene Association), 2018). Supplemental information from other sources for any missing model input parameter values (e.g., typical dry cleaning machine drum volume, residual solvent levels at the end of a cycle, air exchange rates in the work area and in the operator near-field space, solvent addition task time, unloading task time) could be found in other literature sources which then permitted use of higher tier quantitative models such as the two-zone (aka near field-far-field) model to be considered. The ExpoQual rating for the models using the Blando et al. data, on its own merit for modeling, suggest that the data are adequate for qualitative assessment. Using the QEAC, the predicted exposure is multiple orders of magnitude above the ACGIH TLV of 0.1 ppm. This model prediction aligned with -but was higher than -the measured exposure data given in Blando et al. (2010) .
ExpoQual
The results from using ExpoQual to assess the study by Blando et al. (2010) and the application of data to the inhalation and dermal models are presented here.
The ExpoQual selections for evaluation of measured data are shown in Fig. 5 . In considering the Blando et al. (2010) data for model inputs, the results for the inhalation and dermal modeling are shown in Fig. 6 . When considering use of the paper for an IH Mod quantitative inhalation model assessment, the overall uncertainty for modeling was ranked as high and of indeterminate direction. Sufficient details were available to conclude the paper was fit for purpose for a qualitative model. Supplemental information was needed to compliment the data from Blando et al. in order to run the more quantitative model. Therefore conclusions for ExpoQual inputs were based on the following justifications:
Data: High uncertainty with directionality indeterminate. There are not data on, for example, ventilation rates in the work area and operator work zones as well as task duration for solvent addition and for the unloading cycles.
Model: Not applicable. Blando et al. provided measured, not modeled, data.
Scenario: Moderate uncertainty of indeterminate direction. Some core details for scenario development are given, but others must be assumed.
When using the data for a quantitative dermal model, the overall assessment was that the 1-BP data were fit for enabling quantitative dermal health risk assessment. Justifications for decisions regarding direction and magnitude of uncertainty for the assessment of modeled dermal exposure are given here.
Data uncertainty: Medium confidence in the direction of an overestimate of exposure based on the following justification. No skin exposure measurements in Blando et al. Exposed skin area or contact liquid frequency not given for subjects so assumptions are requiredthese were conservative. Good operational characteristics provided by Blando et al. (2010) , e.g., ventilation type, cycles, volumes manually handled were provided which reduce uncertainty in developing estimations. Also knowledge of physical-chemical properties helps overcome uncertainty in skin exposure risk assessment. Plus measured airborne vapor concentrations were given.
Model uncertainty: Medium confidence. Model would overestimate exposure. As IH SkinPerm is most applicable to log Kow −3 to 6 and MW < 600, the substance log Kow at pH 5.5 = 2.1, MW= 123 falls well within the boundary of the model applicability. Exposed skin area or contact liquid frequency not given for subjects, so assumptions are required; conservative assumptions used. Knowledge of physical-chemical properties helps overcome uncertainty in skin exposure risk assessment. Airborne vapor concentrations given in Blando et al. (2010) .
Scenario uncertainty: Medium confidence with unknown direction. Exposure estimate can be derived. Further justifications: Good operational characteristics provided in paper, e.g., ventilation type, cycles, the volumes manually handled were provided. Airborne data provided was limited and results had high CV. Personal samples N = 14 (CV 111%); area samples N = 12 (CV 100%). Data are for three shops operations. Same type equipment in each shop, just shop size, workload, ventilation varied. 
Discussion
Assessments of data quality are not new. Systematic review which includes a data quality evaluation component is an integral consideration in other fields such as clinical trials research and toxicological assessments. Regulatory agencies are also moving in the direction of data quality assessment for environmental risk assessment and decision-making. A transparent and systematic approach to evaluating exposure data will aid in those efforts.
While exposure data are used to support a variety of public health decisions, the question remains: How does one decide in a consistent and transparent way whether any given data source supports a particular decision? There has been a steady progression of instrument development tackling parts of this problem for specific types of exposure data, but one wholly inclusive instrument is not available. Specifically, there is little guidance bridging the gap between evaluating measured exposure data quality and evaluating uncertainty in modeled exposure data, which will be become increasingly necessary as the field of exposure science develops in the current data age. This proliferation of data also means that practical, user-friendly tools are required that serve to support data quality and uncertainty evaluation. It is also important to recognize that exposure model parameters and inputs are often based on measured data, so the quality of these data also serve to inform uncertainty in any exposure estimates resulting from such modeling approaches.
In this paper, we describe an instrument -ExpoQual -that is built upon existing approaches and offers a method for assessing both measured and modeled data in the context of fit-for-purpose decisionmaking. This unified instrument can be used alone or as a data quality component to existing efforts such as HESI RISK21 (Moretto et al., 2017) , computational exposure assessments and related models/software, and to support systematic review efforts where exposure data for a given stressor are evaluated across a range of studies.
ExpoQual does not go as far as risk management and the decision about whether any publication/data source would inform a particular risk assessment is up to the judgment of the risk manager. Having said that, the Expoqual tool would be useful to a risk manager by providing a transparent approach to assessing exposure data quality within and across studies. One of the most difficult aspects in using any data quality assessment instrument is the recognition and acceptance that not all exposure data are equally robust, and that some purposes will require the highest quality data or data with the lowest level of uncertainty. Indeed, in the case of deterministic screening exposure assessment models, the resulting estimates are designed to be conservative (i.e., tend to overestimate) by construction, with an understanding that they are to be used only for particular purposes (typically within a risk assessment context). For example, in the case study involving the Blando et al. paper, the aim was to use contextual information contained in the paper to provide parameter inputs required for a model called IH MOD. Use of the ExpoQual instrument to evaluate exposure information revealed low confidence for this purpose (due to lack of ventilation rates in the work area and operator work zones as well as task duration for solvent addition and for the unloading cycles). This result could be useful to apprise researchers of information needed in future exposure studies to reduce uncertainty and to inform risk assessors of the strengths and weaknesses of these data for exposure modeling with IH MOD. Recognition of the strengths and limitations of data may result in increased interest in sponsoring the collection of measured and modeled data that can produce higher quality/lower uncertainty exposure information, and combined approaches to uncertainty and quality can help inform where resources are best placed in order to achieve the greatest impact when working to improve data quality and/or reduce uncertainty. For example, the case study results highlight the differences in information needs related to inhalation exposure assessments versus dermal exposure assessments.
The development of any instrument is an iterative process. We anticipate with continued use of ExpoQual further enhancements on potential areas for improvement will emerge. We further recognize a sensitivity: efforts to evaluate quality and uncertainty can be perceived negatively and be viewed as means to challenge the scientific literature. However, recognition of areas of strengths and weaknesses in the literature can have the opposite effect by informing funders, researchers and others about aspects of the science that require increased support and innovation.
A key strength of the ExpoQual instrument is that it facilitates a structured approach to exposure data quality evaluation and -using the results of that evaluation -forces an explicit determination with regards to the question of fit-for-purpose. Another strength is the design of ExpoQual to facilitate use as an online tool (freely available at exposure quality.com); the expectation is that early uses with case studies and feedback from the exposure community will result in an evergreen system with instrument advancement. Finally, the instrument was designed to minimize subjectivity and to include transparency in aspects based on professional judgment. ExpoQual will benefit from use under various applications. Through continued use and as modifications from user feedback are incorporated, ExpoQual advancements will continue to provide value for health and environmental decision-making.
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